Replies to post #606825 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

georgebailey, I believe the 20% to 25% estimate that Dr. Liau stated was for a combination of all approximately 600 patients treated with DCVax-L.

That formula would be as follows:

DCVax-L Phase III trial Patients + Information Arm Patients + Compassionate Use Patients + Extended Access Patients

[Roman516]

Interesting, I listened to Dr. Linda Liau's presentation at the 25-minute mark several times and there is no mention of "LL describes long term survival as 20-25%". IMPO.

Per your comment "So what is LL referencing as 20-25%?"
the only comment at the 25-minute mark in Dr. Linda Liau's presentation mention 25 people had over a 5-year survival rate.

https://investorshub.advfn.com/secure/post_reply.aspx?message_id=172271882

The real time frame is,
24 minutes +/- 60 seconds.